These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6329971)

  • 21. Evidence for the role of a cathepsin D-like activity in the release of Gal beta 1-4GlcNAc alpha 2-6sialyltransferase from rat and mouse liver in whole-cell systems.
    McCaffrey G; Jamieson JC
    Comp Biochem Physiol B; 1993 Jan; 104(1):91-4. PubMed ID: 8448997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteinases and proteinase inhibition by cytotoxic and antimetastatic drugs in transplantable solid metastasizing tumors in mice.
    Giraldi T; Sava G; Perissin L; Zorzet S
    Anticancer Res; 1985; 5(4):355-9. PubMed ID: 3898994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis.
    Sumiyoshi K; Baba S; Sakaguchi S; Urano T; Takada Y; Takada A
    Thromb Res; 1991 Jul; 63(1):59-71. PubMed ID: 1948823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer.
    Castiglioni T; Merino MJ; Elsner B; Lah TT; Sloane BF; Emmert-Buck MR
    Hum Pathol; 1994 Sep; 25(9):857-62. PubMed ID: 8088759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the effect of the hepatocyte-stimulating factor on galactose-beta 1----4-N-acetylglucosamine alpha 2----6-sialyltransferase in cultured hepatocytes.
    Woloski BM; Fuller GM; Jamieson JC; Gospodarek E
    Biochim Biophys Acta; 1986 Feb; 885(2):185-91. PubMed ID: 3511971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sialyltransferase activity in tumor tissues.
    Berge PG; Wilhelm A; Schriewer H
    Klin Wochenschr; 1984 Apr; 62(7):331-6. PubMed ID: 6328100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic parameters of a beta-D-galactoside alpha 2 leads to 6 sialyltransferase from embryonic chicken liver.
    Bendiak B; Cook GM
    Eur J Biochem; 1982 Nov; 128(2-3):355-62. PubMed ID: 6759114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the effect of inflammation on rat liver and serum sialyltransferase. Evidence that inflammation causes release of Gal beta 1 leads to 4GlcNAc alpha 2 leads to 6 sialyltransferase from liver.
    Kaplan HA; Woloski BM; Hellman M; Jamieson JC
    J Biol Chem; 1983 Oct; 258(19):11505-9. PubMed ID: 6413502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Protease activities in gastric and colon cancer tissues].
    Chung SM; Kawai K; Chung HM; Kawamoto K; Tada M
    Nihon Shokakibyo Gakkai Zasshi; 1990 Aug; 87(8):1678-85. PubMed ID: 2232301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple forms of plasminogen activator in human breast tumors.
    O'Grady P; Lijnen HR; Duffy MJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6216-8. PubMed ID: 3933824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase and a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase from rat liver.
    Weinstein J; de Souza-e-Silva U; Paulson JC
    J Biol Chem; 1982 Nov; 257(22):13845-53. PubMed ID: 7142180
    [No Abstract]   [Full Text] [Related]  

  • 32. Cathepsin D-like activity in the release of Gal beta 1-4GlcNAc alpha 2-6sialyltransferase from mouse and guinea pig liver Golgi membranes during the acute phase response.
    Lammers G; Jamieson JC
    Comp Biochem Physiol B; 1990; 95(2):327-34. PubMed ID: 2109670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some biochemical properties of human breast tumor sialyltransferase.
    Kishore GS; Budnick RM; Dao TL
    Biochem Med; 1985 Feb; 33(1):1-7. PubMed ID: 2581561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas.
    Santamaría I; Velasco G; Cazorla M; Fueyo A; Campo E; López-Otín C
    Cancer Res; 1998 Apr; 58(8):1624-30. PubMed ID: 9563472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum sialyltransferase follow up control of malignant diseases].
    Ganzinger U; Euler-Rolle J; Baumgartner G; Pawlak E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1212-5. PubMed ID: 206046
    [No Abstract]   [Full Text] [Related]  

  • 36. Collagenase secretion by human breast neoplasms: a clinicopathologic investigation.
    Ogilvie DJ; Hailey JA; Juacaba SF; Lee EC; Tarin D
    J Natl Cancer Inst; 1985 Jan; 74(1):19-27. PubMed ID: 2982053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sialyltransferase probing glycolytic energy metabolism in the plasma membrane.
    Cervén E; Ronquist G
    Naturwissenschaften; 1985 Feb; 72(2):86-8. PubMed ID: 3990825
    [No Abstract]   [Full Text] [Related]  

  • 38. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
    Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
    Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the pattern of cathepsin-D expression in fibroadenoma, fibrocystic disease, preinvasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 1999 Aug; 31(3):247-51. PubMed ID: 10503271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in serum sialyltransferase activities in patients with brain tumors.
    Shen AL; Chou MD; Chi CW; Lee LS
    Surg Neurol; 1984 Nov; 22(5):509-14. PubMed ID: 6495162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.